As a transmembrane P-glycoprotein regulating the efflux of substances as an MDR transporter, ABCB5 regulates the efflux of various substances, potentially enabling skin-derived ABCB5+ MSCs to interfere with drug resistance in cancers such as melanoma, thereby enhancing the efficacy of chemotherapy. This evidence concerns the gene ABCB5 and melanoma.